 | Up a level |
Jump to: 2022
Number of items: 1.
2022
Subbiah, Vivek, Wolf, Jurgen, Konda, Bhavana, Kang, Hyunseok, Spira, Alexander, Weiss, Jared, Takeda, Masayuki, Ohe, Yuichiro, Khan, Saad, Ohashi, Kadoaki, Soldatenkova, Victoria, Szymczak, Sylwia, Sullivan, Loretta, Wright, Jennifer and Drilon, Alexander (2022). Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial. Lancet Oncol., 23 (10). S. 1261 - 1274. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488